niridazole
- CAS NO.:61-57-4
- Empirical Formula: C6H6N4O3S
- Molecular Weight: 214.204
- MDL number: MFCD00128262
- EINECS: 2005126
- SAFETY DATA SHEET (SDS)
- Update Date: 2024-11-15 19:19:13
What is niridazole ?
Description
Niridazole is a yellow, crystalline solid. It is almost insoluble in water and most organic solvents, but it is soluble in dimethylformamide.
The Uses of niridazole
Antischistosomal.
Definition
ChEBI: Niridazole is a C-nitro compound and a member of 1,3-thiazoles.
Indications
Niridazole can be used against blood flukes, especially Schistosoma haematobium. Tolerance and efficacy are reduced in S. mansoni and especially in S. japonicum infections. It is also used in Dracunculus infections. Immunosuppression, vomiting, cramps, dizziness, and headache are among the frequent adverse reactions.
Mechanism of action
Niridazole causes a depletion of glycogen in schistosomes by inducing a reduced rate of conversion of active glycogen phosphorylase to its inactive form. This is achieved through inhibition of the enzyme phosphorylase phosphatase, which normally inactivates glycogen phosphorylase. It is possible that the active moiety is not niridazole, but its 5-imino analog, which can be formed by schistosomes in vitro under anaerobic conditions .
Pharmacology
Niridazole exhibits schistosomicide and amebicidal action. The mechanism of action is not
known. It seems likely that it is concentrated in the parasite organism, which causes inhibition of phosphorylase activation, which is expressed in the depletion of glycogen reserves.
It also may inhibit spermatogenesis of parasites by affecting the production of eggs. It is
used for diseases caused by Dracunculus meddinesis, as well as Shistosoma haematobium
and Shistosoma mansoni. It belongs to a group of tertiary drugs and is used only in the
absence of the drug of choice. Synonyms of this drug are ambilhar and others.
Side Effects
Occasional adverse reactions are diarrhea, electrocardiographic changes, rash, insomnia, and paresthesia. Psychosis, hemolytic anemia, and convulsions are rare. Contraindications are impaired liver function, glucose-6- phosphatedehydrogenase deficiency, epilepsy, and severe heart diseases.
Safety Profile
Confirmed carcinogen with experimental carcinogenic and neoplastigenic data. Poison by intraperitoneal route. Moderately toxic by ingestion. Experimental reproductive effects. Human mutation data reported. Used as an amoebicide and schistosomicidal agent.
Synthesis
Niridazole, 1-(5-nitro-2-thiazolyl)-2-imidazolidinone (38.1.11), is made by reacting 2-amino-5-nitrothiazol with 2-chloroethylisocyanate to make the disubstituted urea (38.1.10). Heating this compound results in an intramolecular N-alkylation reaction to form the desired imidazolidine derivative, niridazole.
Properties of niridazole
Melting point: | 260-262° |
Density | 1.561 (estimate) |
refractive index | 1.6200 (estimate) |
pka | 12.73±0.20(Predicted) |
form | solid |
color | Yellow crystals from DMF/MeOH |
Water Solubility | 0.13g/L(25 ºC) |
IARC | 2B (Vol. 13, Sup 7) 1987 |
EPA Substance Registry System | Niridazole (61-57-4) |
Safety information for niridazole
Computed Descriptors for niridazole
New Products
4-AMINO-TETRAHYDRO-PYRAN-4-CARBOXYLIC ACID 4-Aminotetrahydropyran-4-carbonitrile Hydrochloride (R)-3-Aminobutanenitrile Hydrochloride 4-AMINO-TETRAHYDRO-PYRAN-4-CARBOXYLIC ACID HCL 1,4-Dioxa-8-azaspiro[4.5]decane 5-Bromo-2-nitropyridine SODIUM AAS SOLUTION ZINC AAS SOLUTION BUFFER SOLUTION PH 10.0(BORATE) GOOCH CRUCIBLE SINTERED AQUANIL 5 BERYLLIUM AAS SOLUTION INOSITOL PANTOPRAZOLE SODIUM SESQUIHYDRATE Metformin FLUCLOXACILLIN SODIUM STERILE NIMESULIDE BP ZONISAMIDE 1,1-Dimethylethyl 4-(2-azidoacetyl)-1-piperidinecarboxylate 2-Bromo-1-(bromomethyl)-3-iodo-5-nitrobenzene 1,2-Dibromo-3-(bromomethyl)-5-nitrobenzene 2-Cyano-5-pyrimidineacetonitrile 7-Fluoro-4-cinnolinamine 2-Bromo-1-(bromomethyl)-3-chloro-5-nitrobenzeneRelated products of tetrahydrofuran
You may like
-
1823754-06-8 98%View Details
1823754-06-8 -
2250220-37-0 4-azido-4-methylchromane 98%View Details
2250220-37-0 -
1935373-20-8 3-(Bromomethyl)-6-fluoro-1,2-benzenediamine 98%View Details
1935373-20-8 -
2-Chloro-5-(iodomethyl)pyrimidine 2268818-88-6 98%View Details
2268818-88-6 -
2092793-98-9 98%View Details
2092793-98-9 -
1360944-55-3 7-Methoxy-1H-indol-5-amine 98%View Details
1360944-55-3 -
2090480-14-9 98%View Details
2090480-14-9 -
1-Methyl 2-bromo-5-[(1-carboxy-1-methylethyl)amino]benzoate 1651844-56-2 98%View Details
1651844-56-2